Van Den Houte Maaike, Van Oudenhove Lukas, Van Diest Ilse, Bogaerts Katleen, Persoons Philippe, De Bie Jozef, Van den Bergh Omer
Health Psychology, Faculty of Psychology and Educational Sciences, University of Leuven, Leuven, Belgium.
REVAL - Rehabilitation Research Center, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Front Psychol. 2018 Mar 6;9:275. doi: 10.3389/fpsyg.2018.00275. eCollection 2018.
Several studies have shown that patients with functional somatic syndromes (FSS) have, on average, deficient endogenous pain modulation (EPM), as well as elevated levels of negative affectivity (NA) and high comorbidity with depression and reduced resting heart rate variability (HRV) compared to healthy controls (HC). The goals of this study were (1) to replicate these findings and (2) to investigate the moderating role of NA, depression, and resting HRV in EPM efficiency within a patient group with fibromyalgia and/or chronic fatigue syndrome (CFS). Resting HRV was quantified as the root mean square of successive differences between inter-beat intervals (RMSSD) in rest, a vagally mediated time domain measure of HRV. Seventy-eight patients with fibromyalgia and/or CFS and 33 HC completed a counter-irritation paradigm as a measure of EPM efficiency. Participants rated the painfulness of electrocutaneous stimuli (of individually calibrated intensity) on the ankle before (baseline phase), during (counter-irritation phase) and after (recovery phase) the application of a cold pain stimulus on the forearm. A larger reduction in pain in the counter-irritation phase compared to the baseline phase reflects a more efficient EPM. In contrast to our expectations, there was no difference between pain ratings in the baseline compared to counter-irritation phase for both patients and HC. Therefore, reliable conclusions on the moderating effect of NA, depression, and RMSSD could not be made. Surprisingly, patients reported more pain in the recovery compared to the counter-irritation and baseline phase, while HC did not. This latter effect was more pronounced in patients with comorbid depression, patients who rated the painfulness of the counter-irritation stimulus as high and patients who rated the painfulness of the electrocutaneous stimuli as low. We did not manage to successfully replicate the counter-irritation effect in HC or FSS patients. Therefore, no valid conclusions on the association between RMSSD, depression, NA and EPM efficiency can be drawn from this study. Possible reasons for the lack of the counter-irritation effect are discussed.
多项研究表明,与健康对照组(HC)相比,功能性躯体综合征(FSS)患者平均存在内源性疼痛调制(EPM)缺陷、负性情感(NA)水平升高、与抑郁症的高共病率以及静息心率变异性(HRV)降低。本研究的目的是:(1)重复这些发现;(2)在纤维肌痛和/或慢性疲劳综合征(CFS)患者组中,研究NA、抑郁症和静息HRV在EPM效率中的调节作用。静息HRV被量化为静息状态下逐搏间期连续差值的均方根(RMSSD),这是一种由迷走神经介导的HRV时域测量方法。78名纤维肌痛和/或CFS患者以及33名HC完成了一项对抗刺激范式,作为EPM效率的测量指标。参与者在对前臂施加冷痛刺激之前(基线期)、期间(对抗刺激期)和之后(恢复期),对脚踝处电皮肤刺激(个体校准强度)的疼痛程度进行评分。与基线期相比,对抗刺激期疼痛减轻幅度更大反映了EPM更有效。与我们的预期相反,患者和HC在基线期与对抗刺激期的疼痛评分没有差异。因此,无法就NA、抑郁症和RMSSD的调节作用得出可靠结论。令人惊讶的是,与对抗刺激期和基线期相比,患者在恢复期报告的疼痛更多,而HC则没有。后一种效应在合并抑郁症的患者、将对抗刺激刺激的疼痛程度评为高的患者以及将电皮肤刺激的疼痛程度评为低的患者中更为明显。我们未能在HC或FSS患者中成功重复对抗刺激效应。因此,本研究无法就RMSSD、抑郁症、NA与EPM效率之间的关联得出有效结论。讨论了缺乏对抗刺激效应的可能原因。